Here is the company’s cap structure. As background, Novo has a terrific balance sheet, generates huge returns on equity and is relatively inexpensive at 15.4x 2025 earnings estimates.

Novo Nordisk stock ... The new weight-loss drug company emerged from stealth with big plans to take on obesity drugs like Wegovy and Zepbound. Novo Nordisk’s weight-loss wonder drugs could ...

Healthcare & Pharmaceuticalscategory· December 20, 2024 Weight-loss drug developers line up to tap market worth $150 billion Novo Nordisk's ... June 3, 2024 Structure's obesity pill surpasses ...

Joining the consortium are Bristol Myers Squibb, COGNANO, Lambda, Novo Nordisk ... Design. Structure Therapeutics, headquartered in San Francisco, California, is a biotechnology company focused ...